BioCentury
ARTICLE | Clinical News

PYY3-36: Phase II started

August 22, 2005 7:00 AM UTC

NSTK started a Phase II trial. The trial start triggered an undisclosed payment from NSTK to Thiakis. Last September, NSTK acquired from Thiakis exclusive rights to patent applications covering periph...